10/29/2026
A significant step forward for patient access and provider choice.
The FDA has announced a policy restoring access to previously restricted peptides through licensed compounding pharmacies.
Thank you to the U.S. Department of Health and Human Services and the FDA for listening to patients and practitioners, and for standing up for the licensed pharmacies that do this work the right way.
For EVEXIAS Health Solutions and FarmaKeio Pharmacy Network, this marks an important milestone in the ongoing effort to expand responsible access to personalized treatment options. And to the providers and patients who spoke up along the way: this is yours too.
As access returns, we encourage patients to work with their providers and get peptides only from licensed compounding pharmacies, not “research use only” sellers.
We remain committed to supporting providers with the education, resources and pharmacy solutions they need as this policy moves toward implementation. More details to come.